Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

5α-reductase inhibitors like finasteride and dutasteride can help treat skin disorders stimulated by androgens, such as hair loss and acne.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Dutasteride may reduce insulin sensitivity and increase body fat.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Inhibiting testosterone 5alpha-reductase may help treat benign prostatic hyperplasia.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Patients with mood disorders using 5α-reductase inhibitors may have a higher risk of suicidal thoughts.

Treatment with 5α-reductase inhibitors is linked to a delay in prostate cancer diagnosis and may affect survival rates.

Combining 5α-reductase and aromatase inhibitors may better reduce estrogen levels.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

A new compound effectively inhibits human 5α-reductase 1.

Using 5α-reductase inhibitors for hair loss may increase the risk of dry eye disease.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Rats had lasting erectile problems after stopping a certain medication.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Steroid sulfatase inhibitors could help treat hormone-related disorders and cancers.